Arsenic trioxide induces G2/M growth arrest and apoptosis after caspase-3 activation and bcl-2 phosphorylation in promonocytic U937 cells

被引:108
作者
Park, JW
Choi, YJ
Jang, MA
Baek, SH
Lim, JH
Passaniti, T
Kwon, TK
机构
[1] Keimyung Univ, Sch Med, Dept Immunol, Taegu 700712, South Korea
[2] Yeungnam Univ, Coll Med, Dept Biochem & Mol Biol, Taegu, South Korea
[3] Univ Maryland, Sch Med, Greenebaum Canc Ctr, Baltimore, MD 21201 USA
关键词
arsenic trioxide; apoptosis; bcl-2; phosphorylation; cell cycle; leukemia;
D O I
10.1006/bbrc.2001.5416
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Arsenic trioxide has recently been shown to inhibit growth and induce apoptosis in acute promyelocytic leukemia (APL), but little is known about the molecular mechanisms mediating these effects. Here we demonstrate that treatment of promonocytic U937 cells with arsenic trioxide leads to G2/M arrest which was associated with a dramatic increase in the levels of cyclin B and cyclin B-dependent kinase and apoptosis. We further show that apoptosis occurs after bcl-2 phosphorylation and caspase-3 activation followed by cleavage of PARP and PLC-gamma1 degradation and DNA fragmentation. The arsenic trioxide-induced apoptosis could be blocked by the protein synthesis inhibitor cycloheximide. In addition, pretreatment of U937 cells with the DNA polymerase inhibitor aphidicolin also blocked apoptosis, but did not cause the arrest of cells in the G2/M phase. The findings suggest that arsenic trioxide exerts its growth-inhibitory effects by modulating expression and/or activity of several key G2/M regulatory proteins. Furthermore, arsenic trioxide-mediated G2/M arrest correlates with the onset of apoptosis. (C) 2001 Academic Press.
引用
收藏
页码:726 / 734
页数:9
相关论文
共 36 条
[21]  
2-1
[22]   PRINCIPLES OF CDK REGULATION [J].
MORGAN, DO .
NATURE, 1995, 374 (6518) :131-134
[23]   IDENTIFICATION AND INHIBITION OF THE ICE/CED-3 PROTEASE NECESSARY FOR MAMMALIAN APOPTOSIS [J].
NICHOLSON, DW ;
ALI, A ;
THORNBERRY, NA ;
VAILLANCOURT, JP ;
DING, CK ;
GALLANT, M ;
GAREAU, Y ;
GRIFFIN, PR ;
LABELLE, M ;
LAZEBNIK, YA ;
MUNDAY, NA ;
RAJU, SM ;
SMULSON, ME ;
YAMIN, TT ;
YU, VL ;
MILLER, DK .
NATURE, 1995, 376 (6535) :37-43
[24]   Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: Remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients [J].
Niu, C ;
Yan, H ;
Yu, T ;
Sun, HP ;
Liu, JX ;
Li, XS ;
Wu, W ;
Zhang, FQ ;
Chen, Y ;
Zhou, L ;
Li, JM ;
Zeng, XY ;
Yang, RRO ;
Yuan, MM ;
Ren, MY ;
Gu, FY ;
Cao, Q ;
Gu, BW ;
Su, XY ;
Chen, GQ ;
Xiong, SM ;
Zhang, TD ;
Waxman, S ;
Wang, ZY ;
Chen, Z ;
Hu, J ;
Shen, ZX ;
Chen, SJ .
BLOOD, 1999, 94 (10) :3315-3324
[25]  
Park WH, 2000, CANCER RES, V60, P3065
[26]   Double identity for proteins of the Bcl-2 family [J].
Reed, JC .
NATURE, 1997, 387 (6635) :773-776
[27]   Butyrate mediates Caco-2 cell apoptosis via up-regulation of pro-apoptotic BAK and inducing caspase-3 mediated cleavage of poly-(ADP-ribose) polymerase (PARP) [J].
Ruemmele, FM ;
Dionne, S ;
Qureshi, I ;
Sarma, DSR ;
Levy, E ;
Seidman, EG .
CELL DEATH AND DIFFERENTIATION, 1999, 6 (08) :729-735
[28]  
Shen SC, 1998, CELL GROWTH DIFFER, V9, P23
[29]   Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APE) .2. Clinical efficacy and pharmacokinetics in relapsed patients [J].
Shen, ZX ;
Chen, GQ ;
Ni, JH ;
Li, XS ;
Xiong, SM ;
Qiu, QY ;
Zhu, J ;
Tang, W ;
Sun, GL ;
Yang, KQ ;
Chen, Y ;
Zhou, L ;
Fang, ZW ;
Wang, YT ;
Ma, J ;
Zhang, P ;
Zhang, TD ;
Chen, SJ ;
Chen, Z ;
Wang, ZY .
BLOOD, 1997, 89 (09) :3354-3360
[30]   INHIBITORS OF MAMMALIAN G(1) CYCLIN-DEPENDENT KINASES [J].
SHERR, CJ ;
ROBERTS, JM .
GENES & DEVELOPMENT, 1995, 9 (10) :1149-1163